You are Here: Drug LitigationActos

Actos: A Brief Overview:

Actos, also known as Pioglitazone, is a prescription drug approved by the FDA to treat type 2 diabetes mellitus. Actos is prescribed in combination with diet and exercise to lower the amount of glucose in the bloodstream and to reduce insulin resistance. Actos can be used in treatment alone or in combination with another diabetes drug. Manufactured by Japanese drug company Takeda Pharmaceuticals, Actos was the tenth best selling drug in the US in 2008, with sales of over $2.4 billion and $4.8 billion worldwide. Although some research has suggested that Actos is safer than the competing drug Avandia for risk of cardiac events, other studies have indicated that a dangerous possible side effect of Actos is an increased risk of bladder cancer. As a result, Actos has been subject to recalls in Europe. In the US, the FDA issued a drug safety communication to inform the public of the potential risk of bladder cancer, ordered an Actos safety review, and required updated drug label safety warnings. Actos bladder cancer lawsuits against Takeda Pharmaceuticals have recently begun and are expected to increase as potential cases of bladder cancer among Actos patients are investigated.

Please read on to learn more about the Actos Drug Safety Communication and how to protect your rights:

Actos European Recalls: A Brief Overview:

Actos (pioglitazone) is a diabetes drug manufactured by the Japanese firm Takeda Pharmaceuticals. Actos is a blockbuster drug in the United States, with over two million prescriptions filled in 2010..... More...

The Actos Safety Review: What is it all about?

In September 2010, the Food and Drug Administration ordered a safety review of Actos based on preliminary data indicating a possible risk of bladder cancer.... More...

FDA Drug Safety Communication: What you should know.

On June 15, 2011, the Food and Drug Administration released a safety communication to inform the public of a possible increased risk of bladder cancer in patients taking Actos for longer than one year.... More...

The Dangers of Actos: Increased Risks of Bladder Cancer, Heart Failure, and Death

Actos (pioglitazone hydrochloride) is a prescription drug in the class of drugs called thiazolidinediones. Actos is one of the most commonly prescribed drugs for treatment of type II diabetes.... More...

Actos Lawsuits: A Brief Overview:

Actos is manufactured by Takeda Pharmaceuticals. Actos bladder cancer lawsuits against Takeda have recently begun, the first lawsuits being filed in August 2011.... More...

How We Can Help:

As a qualified products liability law firm, Sullo & Sullo is able to help you in several very important ways: More...

Free Consultation  Call Now

Get Interactive

Sullo & Sullo-Facebook Sullo & Sullo-Linkedin Sullo & Sullo-Twitter Sullo & Sullo-You Tube
Free Consultation
Receive an immediate response to your request.
Choose the practice area your problem:

I understand and agree that submitting this form does not create an attorney-client relationship and that the information I submit is not confidential or privileged and may be shared. I further understand and agree to the Terms of Use and Privacy Policy


Recent Articles & Publications

November 25, 2013
Iclusig, a drug manufactured by Ariad Pharmaceuticals to treat resistant chronic myeloid leukemia, gained FDA approval last December—almost three months ahead of the anticipated...

November 22, 2013
Sales of Iclusig, a drug used primarily in the treatment of chronic myeloid leukemia, were recently suspended in a joint decision between the FDA and Ariad Pharmaceuticals,...

November 20, 2013
Recently, Ariad Pharmaceuticals and the FDA have jointly decided to suspend sales of Iclusig, a drug used in the treatment of chronic myeloid leukemia and Philadelphia chromosome...